Clinical Trials Directory

Trials / Suspended

SuspendedNCT04109807

Effects of Low Dose Ozone on Airway Inflammatory Responses in Adults With Asthma - Sedentary Nasal Ozone (Asthma SNOZ)

Effects of Low Dose Ozone on Airway Inflammatory Responses in Adults With Asthma Asthma SNOZ

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
18 (estimated)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

To determine if low levels of ozone (O3) encountered on a typical day in Chapel Hill will decrease spirometric values in mild asthmatics.

Detailed description

Short-term exposure to ambient air ozone has been recognized for decades to be adversely associated with impacts on the respiratory system. Indeed the evidence is such that the Environmental Protection Agency (EPA) has determined that there is a causal relationship, and even lowered the 8-hour exposure standard to 0.07 parts per million (ppm) in 2015. Controlled human exposure studies and epidemiological studies have consistently observed ozone-associated decrements in lung function and increased respiratory symptoms. Most controlled human exposure studies have been performed with high ozone concentrations. Additionally, epidemiologic studies have focused on populations engaged in outdoor activities (increasing ozone exposure through increased minute ventilation), or in cities such as Los Angeles or Mexico City where ambient ozone levels are especially high. Evidence has recently emerged that exposure to low ozone concentrations also produces adverse health effects, especially among susceptible groups including children with asthma. The objective of this study is to examine if low level ozone exposure (compared to a clean air exposure), reflective of a typical metropolitan summer day, will cause decrements in lung function and measurable upper and lower airway inflammation in mild asthmatics (who are not on asthma controller medications) while performing typical daily activities.

Conditions

Interventions

TypeNameDescription
OTHEROzoneozone exposure
OTHERFAFiltered air exposure

Timeline

Start date
2019-12-16
Primary completion
2027-08-01
Completion
2027-08-01
First posted
2019-09-30
Last updated
2025-12-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04109807. Inclusion in this directory is not an endorsement.